[go: up one dir, main page]

WO1996003436A3 - EQUINE η-INTERFERON - Google Patents

EQUINE η-INTERFERON Download PDF

Info

Publication number
WO1996003436A3
WO1996003436A3 PCT/GB1995/001732 GB9501732W WO9603436A3 WO 1996003436 A3 WO1996003436 A3 WO 1996003436A3 GB 9501732 W GB9501732 W GB 9501732W WO 9603436 A3 WO9603436 A3 WO 9603436A3
Authority
WO
WIPO (PCT)
Prior art keywords
interferon
equine
recombinant
polynucleotide fragment
recombinant vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB1995/001732
Other languages
French (fr)
Other versions
WO1996003436A2 (en
Inventor
David Edward Onions
Lesley Nicholson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Q-one Biotech Ltd
Original Assignee
Q-one Biotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Q-one Biotech Ltd filed Critical Q-one Biotech Ltd
Priority to AU30832/95A priority Critical patent/AU3083295A/en
Publication of WO1996003436A2 publication Critical patent/WO1996003436A2/en
Publication of WO1996003436A3 publication Critical patent/WO1996003436A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention provides a polynucleotide fragment encoding equine η-interferon, a recombinant vector comprising such a polynucleotide fragment, a host cell containing said polynucleotide fragment or recombinant vector, a recombinant equine η-interferon polypeptide, and pharmaceutical compositions comprising recombinant η-interferon for use as a prophylactic and/or therapeutic agent and also as an adjuvant.
PCT/GB1995/001732 1994-07-21 1995-07-21 EQUINE η-INTERFERON Ceased WO1996003436A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU30832/95A AU3083295A (en) 1994-07-21 1995-07-24 Equine gamma-interferon

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9414753.5 1994-07-21
GB9414753A GB2291645A (en) 1994-07-21 1994-07-21 Equine gamma-interferon

Publications (2)

Publication Number Publication Date
WO1996003436A2 WO1996003436A2 (en) 1996-02-08
WO1996003436A3 true WO1996003436A3 (en) 1996-10-03

Family

ID=10758695

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1995/001732 Ceased WO1996003436A2 (en) 1994-07-21 1995-07-21 EQUINE η-INTERFERON

Country Status (3)

Country Link
AU (1) AU3083295A (en)
GB (1) GB2291645A (en)
WO (1) WO1996003436A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3642096A1 (en) * 1986-12-10 1988-06-16 Boehringer Ingelheim Int HORSE (GAMMA) INTERFERON
WO1992003574A1 (en) * 1990-08-13 1992-03-05 The University Of Melbourne Cytokine production
WO1992005255A1 (en) * 1990-09-13 1992-04-02 Commonwealth Scientific And Industrial Research Organisation Ovine cytokine genes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3642096A1 (en) * 1986-12-10 1988-06-16 Boehringer Ingelheim Int HORSE (GAMMA) INTERFERON
EP0271824A2 (en) * 1986-12-10 1988-06-22 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Horse gamma interferon
WO1992003574A1 (en) * 1990-08-13 1992-03-05 The University Of Melbourne Cytokine production
WO1992005255A1 (en) * 1990-09-13 1992-04-02 Commonwealth Scientific And Industrial Research Organisation Ovine cytokine genes

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CURRAN J.A. ET AL.: "Nucleotide sequence of the equine interferon gamma cDNA", DNA SEQUENCE, vol. 4, no. 6, pages 405 - 407 *
GRÜNIG G. ET AL.: "Cloning and sequencing of horse interferon-gamma cDNA", IMMUNOGENETICS, vol. 39, no. 6, 28 April 1994 (1994-04-28), pages 448 - 449 *
YILMA T. ET AL.: "Preliminary characterization of equine Interferons and their antiviral activities on bovine, ovine and human cells", J. INTERFERON RES., vol. 2, no. 3, pages 363 - 370 *

Also Published As

Publication number Publication date
AU3083295A (en) 1996-02-22
GB9414753D0 (en) 1994-09-07
GB2291645A (en) 1996-01-31
WO1996003436A2 (en) 1996-02-08

Similar Documents

Publication Publication Date Title
WO1996017072A3 (en) Recombinant alphavirus vectors
WO1995007994A3 (en) Recombinant alphavirus vectors
AUPP051497A0 (en) Antimicrobial peptides
EP1231218A3 (en) An appetite-suppressing peptide, its compositions and use
EP0962467A4 (en) Antibody against human parathormone related peptides
IL130102A (en) Aminoguanidines and alkoxyguanidines as protease inhibitors, pharmaceutical compositions containing the same and processes for preparing the same
WO2001053455A3 (en) Novel nucleic acids and polypeptides
AU6743294A (en) Xylanase derived from a bacillus species, expression vectors for such xylanase and other proteins, host organismstherefor and use thereof
EP0659769A3 (en) Agent for promoting the proliferation of bifidobacterium.
WO1999058562A3 (en) Novel compounds
AU8812498A (en) Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest
WO1999055873A3 (en) Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
BR0312889A (en) Pegged t20 polypeptide
WO1996003435A3 (en) FELINE η-INTERFERON
AU6292694A (en) Novel polypeptide, dna coding for said polypeptide, recombinant vector containing said dna, recombinant virus prepared using said vector, and use thereof
WO2000058465A3 (en) Flint polypeptide analogs
GB9820003D0 (en) Novel compounds
WO1996003436A3 (en) EQUINE η-INTERFERON
WO1997005251A3 (en) Feline stem cell factor
GB9809683D0 (en) Novel compounds
EP0911409A3 (en) Deformylase
GB9810285D0 (en) Novel compounds
WO1999031229A3 (en) Peptides and nucleic acids derived from eisenia foetida and the use thereof
AU4505099A (en) (moraxella catarrahalis) polynucleotides and polypeptides
AU4504999A (en) Novel compounds

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase